Pa. Court Affirms $10M Prempro Judgment Against Pfizer

Law360, New York (July 23, 2012, 6:27 PM EDT) -- A Pennsylvania appeals court on Friday upheld a $10.4 million damages award leveled against a Pfizer Inc. unit for its failure to warn of the risks allegedly posed by the hormone replacement therapy Prempro, backing expert testimony linking the drug to breast cancer.

The decision is one of the first Prempro rulings to come down since Pfizer announced in May that it had set aside $330 million to settle the remaining claims related to hormone replacement therapies. About 60 percent of the 10,000 suits filed in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.